Harrow Health, Inc.HROWNASDAQ
LOADING
|||
Switch Symbol:
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +43.75% | +83.83% | +38.29% | +30.25% | +45.44% |
| Gross Profit Growth | +53.89% | +110.34% | +34.42% | +30.53% | +44.81% |
| EBITDA Growth | -7.38% | +0.00% | +0.00% | +264.89% | +171.78% |
| Operating Income Growth | -24.25% | +0.00% | +0.00% | +645.69% | +1016.35% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +4.22% | +1.28% | +1.00% | +3.29% | +4.04% |
| Weighted Average Shares Diluted Growth | +4.22% | +1.28% | +1.00% | +9.08% | +8.89% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | -304.45% | +0.00% | +0.00% | +462.11% |
| Free Cash Flow Growth | +0.00% | -751.58% | +0.00% | +0.00% | +597.83% |
| Receivables Growth | +188.63% | +219.55% | +164.80% | +50.95% | +44.23% |
| Inventory Growth | +13.81% | -1.52% | -0.87% | +22.57% | +26.37% |
| Asset Growth | +22.89% | +24.77% | +23.22% | +12.52% | +3.28% |
| Book Value per Share Growth | -26.57% | -2.26% | -7.71% | -17.87% | -22.06% |
| Debt Growth | +3.35% | +20.12% | +20.01% | +20.23% | +28.46% |
| R&D Expense Growth | +59.96% | +42.54% | +40.81% | -6.06% | +46.19% |
| SG&A Expenses Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |